Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy-Reference-Cited by-同舟云学术

Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy

Published:2024-09 Issue: Volume:201 Page:104424
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Ruglioni Martina,Crucitta Stefania,Luculli Giovanna Irene,Tancredi Gaspare,Del Giudice Maria Livia,Mechelli Sandra,Galimberti Sara,Danesi Romano^ORCID,Del Re Marzia

Publisher

Elsevier BV

Reference209 articles.

1. Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21Cdkn1a and Pbx1 in Hematopoietic Cells;Abe;PLoS One,2016

2. Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia;Abou Dalle;Blood Cancer J.,2020

3. The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression;Abraham;Leukemia,2017

4. Identification of three novel DNMT3A mutations with compromising methylation capacity in human acute myeloid leukaemia;Ali;Mol. Biol. Rep.,2022

5. Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia;Al-Jamal;BMC Cancer,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia;International Journal of Molecular Sciences;2024-08-30

2. Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments;Current Opinion in Oncology;2024-08-27

3. Molecular Features and Treatment Paradigms of Acute Myeloid Leukemia;Biomedicines;2024-08-06